Try our beta test site
5 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) AND Zanolimumab [TREATMENT]
Show Display Options
Rank Status Study
1 Completed HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
Condition: T Cell Lymphoma
Intervention: Biological: HuMax-CD4
2 Completed Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: HuMax-CD4
3 Completed Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: HuMax-CD4
4 Terminated CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Condition: T-cell Lymphoma
Interventions: Biological: CHOP + CD4;   Drug: CHOP
5 Terminated Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: HuMax-CD4 (zanolimumab)

Study has passed its completion date and status has not been verified in more than two years.